Featured Stories
New York Property Owners Challenge Binghamton Fracking Ban

New York Property Owners Challenge Binghamton Fracking Ban

According to a Reuters report, the landowners believe the Binghamton, N.Y., city council and Mayor acted against proper protocol when voting to ban fracking drilling the the city. Instead, they feel the city should have consulted with the Broome County Planning Commission before approving the ban.

Read More

Zadroga Act Cancer Decision Expected This Week

Zadroga Act Cancer Decision Expected This Week

The federal official tasked with determining what ailments should be covered by the federal Zadroga Act is expected to decide by Saturday if certain cancers will be eligible for compensation. The decision is being eagerly awaited by thousands of first responders who believe they developed cancer due to exposure ...

Read More

Canadian Study Confirms Actos Bladder Cancer Risk

Canadian Study Confirms Actos Bladder Cancer Risk

A new study conducted by Canadian researchers has found that users of the type 2 diabetes drug, Actos (pioglitazone), may face a higher risk of developing bladder cancer than first thought. The study, published in the British Medical Journal, found that taking Actos for two years doubles the likelihood ...

Read More

Actos Whistleblower Lawsuit Questions Avandia Researcher’s Financial Ties to Takeda

Actos Whistleblower Lawsuit Questions Avandia Researcher's Financial Ties to Takeda

A prominent researcher has been implicated in an alleged cover-up of Actos side effects, according to a report from TheHeart.org. An Actos whistleblower lawsuit unsealed earlier this year has alleged financial connections between the Cleveland Clinic’s Dr Steven Nissen and the maker of Actos “should be considered when analyzing Actos’s ...

Read More

Majority of Metal-on-Metal Hip Implant Failures Occur within Two Years, Study Finds

Majority of Metal-on-Metal Hip Implant Failures Occur within Two Years, Study Finds

A newly published metal-on-metal hip replacement study is reporting that the majority of failures occur early, within two years of surgery. The study, published in the journal Orthopedics, is just the latest to indicate that close follow-up of metal-on-metal hip implant patients is warranted.

Read More

FDA Advisors Set to Examine Metal-on-Metal Hip Implant Safety Concerns

FDA Advisors Set to Examine Metal-on-Metal Hip Implant Safety Concerns

Thousands of people with metal-on-metal hip implant devices could soon get some answers from the U.S. Food & Drug Administration (FDA) about the dangers they face. Tomorrow, the agency will convene a panel of outside medical experts to examine the safety record of metal-on-metal hip replacements, and recommend the ...

Read More

Federal Judge Certifies Medtronic Infuse Shareholder Class Action Lawsuit

Federal Judge Certifies Medtronic Infuse Shareholder Class Action Lawsuit

A shareholder lawsuit alleging Medtronic Inc. illegally promoted the off-label use of its Infuse bone growth product has been granted class action status by U.S. District Judge Paul Magnuson of Minnesota. According to a report from Law360.com, the Medtronic Infuse off-label promotion lawsuit was filed by several institutional investors on ...

Read More

Bisphosphonate Study Confirms Atypical Thigh Fracture Risk

Bisphosphonate Study Confirms Atypical Thigh Fracture Risk

New research has confirmed the link between bisphoshonates, such as Fosamax, and atypical femur fractures, a type of thigh fracture that occurs spontaneously, without any major leg injury. The study, published in the Archives of Internal Medicine, also found that the risk of atypical thigh fractures increases the longer a ...

Read More

Smith & Nephew Recalls Metal-on-Metal Hip Implant Component

Smith & Nephew Recalls Metal-on-Metal Hip Implant Component

Medical device maker, Smith & Nephew, just issued a recall for a metal-on-metal hip implant component, a part of one of its all-metal hip replacement systems.

Read More

Patients with Knee Problems May Want to Reconsider before Undergoing Knee Replacement

Getting a total knee replacement may seem like an appealing option for someone suffering from sore and creaky knees, but these devices may not be as beneficial as one would hope, according to Well, the New York Times health blog. In 2012, more than 600,000 knee replacement surgeries were performed compared to about 250,000 just 15 years ago.

Manufacturers of knee replacements often claim that the devices have a wide variety of benefits, offering increased mobility, less pain and overall a more youthful lifestyle. However, a growing body of evidence shows that many patients should try other methods to improve their knees first. Research suggests that many people are undergoing the procedures prematurely and gaining limited benefit. Figures from the American Academy of Orthopaedic Surgeons shows that in between the ages of 45 and 64, the number of knee replacements increased drastically by 205 percent between 2000 and 2012. The increase was only 95 percent in people 65 and older. Continue reading

Posted in Legal News |

Energy Drinks Can be Deadly for Children

New research shows that children face serious and possibly deadly side effects from the consumption of energy drinks.

Between 2010 and 2013, poison control centers received more than 5,000 reports of people who got sick from energy drinks, NBC News reports. Many of the cases involved serious side effects, such as seizures, irregular heart rhythmor dangerously high blood pressure, the researchers told a meeting of the American Heart Association. Children under age 6 often consumed energy drinks without knowing what they were drinking. Dr. Steven Lipshultz, co-author of the study and head of pediatrics at the Children’s Hospital of Michigan, said, “They . . . found it in the refrigerator, or left by a parent or an older sibling.” Continue reading

Posted in Food Products, Health Concerns |

Regulators Review Death Risk Associated with Long-Term Use of Duel Antiplatelet Therapy

Preliminary data from a clinical trial has prompted safety regulators to review the safety of using duel antiplatelet therapy long-term. On Sunday, the U.S. Food and Drug Administration (FDA) issued a safety announcement stating that it was evaluating this data.

The data stemmed from The Dual Antiplatelet Therapy (DAPT) trial; findings were published in the New England Journal of Medicine on November 16th. Although the study found a decreased risk of heart attacks and clot formation in stents with 30 months of dual antiplatelet therapy, there was an overall higher risk of death compared to 12 months of treatment. Researchers looked at patients who underwent dual treatment with the aspirin plus either clopidogrel (Plavix) or prasugrel (Effient) after undergoing stent implantation. Stents are often used in patients with narrowed arteries; they are essentially tubes that are intended to maintain blood flow and keep the vessels open.

“We are communicating this safety information while we continue to evaluate the results from this trial and other available data. We will communicate our final conclusions and recommendations when our evaluation is complete.” the FDA stated. Continue reading

Posted in Legal News |

Johnson & Johnson to Pay More than $2.2 Billion in Civil and Criminal Settlements

Health care giant Johnson & Johnson and its subsidiaries will pay more than $2.2 billion to resolve criminal and civil cases arising from allegations relating to the drugs Risperdal (risperidone), Invega (paliperidone) and Natrecor (nesiritide). The allegations include promotion for uses not approved as safe and effective by the Food and Drug Administration (FDA) and payment of kickbacks to physicians and to Omnicare Inc., the largest pharmacy provider to nursing homes.

The global resolution is one of the largest health care fraud settlements in U.S. history, with criminal fines and forfeiture totaling $485 million and civil settlements with the federal government and states totaling $1.72 billion, according to a news release from the Department of Justice. Continue reading

Posted in Health Concerns, Legal News, Pharmaceuticals |

Compensation Claim Deadline Extended for Victims of Defective GM Ignition Switch

The deadline to file an injury or death claim related to General Motors Co.’s ignition switch defect has been extended by one month. Wall Street Journal reports that the GM compensation expert extended the deadline as a result of pressure from safety advocates, politicians and attorneys. Continue reading

Posted in Legal News |

Overtreatment with Anticoagulant May Raise the Risk of Dementia

Long-term overtreatment with the anti-clotting drug warfarin, combined with antiplatelet therapy with aspirin or clopidigrel (Plavix) to prevent stroke, may raise the risk of dementia in people with atrial fibrillation.

The research was presented at the American Heart Association’s Scientific Sessions 2014, MedicalXpress reports. Continue reading

Posted in Health Concerns, Pharmaceuticals, Plavix |

Walgreens Customers Overcharged for Medical Records, Reports Allege

Walgreens, the largest drug retailer in the United States, allegedly overcharged some customers for medical records. At least one lawsuit has been filed alleging that the firm violated state laws by charging overly high fees. The man suing Walgreens alleges he was charged a flat fee of $55 for his medical records.

The suit argues that state law puts a cap on the maximum amount a company is allowed to charge. In this case, the legal limit is $24.81 in handling charges, $0.93 per page for the first 25 pages, $0.62 per page for the next 25 pages and $0.31 for any more than 50 pages. By intentionally exceesing these limits, Walgreens perpetrated the “common scheme of fraud” and violated the Illinois Consumer Fraud and Deceptive Business Practices Act and the Uniform Deceptive Trade Practices Act, the lawsuit alleges. The company is also accused of trying to cover-up the scheme by describing fees in an ambiguous, unclear way. Walgreens is also accuse of common fraud law and unjust enrichment in the suit. Continue reading

Posted in Legal News |

Laundry Detergent Pods Pose Poisoning Risk to Young Children

A report to appear today in the journal Pediatrics says there has been a significant increase in the number of children suffering adverse effects from exposure to the popular laundry detergent “pods” sold across the country.

The pods have become popular because of their convenience – the user does not have to measure the detergent or fabric softener. But many of the pods are colorful and attractive to young children, who eat the pods or inhale the ingredients when they break the outer shell of the pod. If ingested, the highly concentrated detergent in the pods can cause excessive vomiting, lethargy, and gasping, according to Consumer Reports magazine. In some reported cases, victims stopped breathing and required ventilation support. A summary on the Pediatrics web site reports that “17,230 children younger than 6 years [were] exposed to laundry detergent pods in 2012–2013. From March 2012 to April 2013, the monthly number of exposures increased by 645.3%, followed by a 25.1% decrease from April to December 2013” Fox News reports (fox17online.com). Continue reading

Posted in Defective Products, Health Concerns |

Study Links Cell Phone Use to Deadly Brain Cancer

A study suggests that heavy mobile phone use is linked to glioma, a deadly type of brain cancer. Researchers found that the rate of glioma development is related to the the number of hours of use.

The study, which was published in the journal Pathophysiology, was led by researcher Dr. Lennart Hardell, an oncologist from University Hospital in Orebro, Sweden. He and his colleagues compared the hours of mobile phone use between a group of 1,380 patients with malignant brain tumors and a matched group without tumors. Continue reading

Posted in Legal News |

Government Food Pesticide Testing Does Not Include Many Common Pesticides

A report from the Government Accountability Office (GAO) says the Food and Drug Administration (FDA) does not perform enough pesticide residue tests on either imported or domestic foods to say whether the American food supply is safe.

According to the GAO report, the FDA is testing less than one-tenth of 1 percent of imported fruits and vegetables and less than 1 percent of domestic fruits and vegetables, the Washington Post reports. This makes it impossible for the FDA to meet its mandate to “determine the national incidence and level of pesticide residues in the foods it regulates.” Continue reading

Posted in Health Concerns, Toxic Substances |

© 2005-2014 Parker Waichman LLP ®. All Rights Reserved.